Research & development is the lifeblood of the biotech industry.
BioSpectrum
in this special issue has brought together some of the R&D
leaders from the industry to share their thoughts on the “Game Changers
in Drug Discovery & Development�.
Later this month, BioSpectrum is organizing the second edition of the
BioSpectrum Technology Forum 2011 (BSTF 2011) which has a series on
interactive panel discussions with the same theme: “Game Changers in
Drug Discovery & Development.� This two-day forum will be held in
Bangalore on February 22-23, 2011.
During these two days, senior scientists and R&D heads from public
and private sectors across the country will be sharing their insights
& experiences on topics such as “Stem Cells & Gene Therapy,
Next Generation Innovation, Strengthening the Drug Pipeline,
Computer-aided Drug Discovery, and Novel Approaches to Drug Discovery.�
In the ensuing pages, read on some insights from these R&D leaders:
(The views expressed in these articles are strictly the personal
views of the author. The trademarks or trade names mentioned in this
paper are property of their respective owners and are included for
reference only and do not imply a connection or relationship between
the author and these companies or BioSpectrum.)
Mr
Venkat
Jasti,chairman & CEO, Suven Life Sciences
Dr
Arumugam
Muruganandam, Chief Scientific Manager Research &
Development Biocon
Dr
Chandra
Viswanathan, Head, Regenerative Medicine, Reliance Life
Sciences
Dr
Gopal
Dasika, VP, Biotech, Unichem
Dr
Samuel
JK Abraham, Director, Nichi-In Centre for Regenerative
Medicine
Dr
Janakiraman
Ramachandran, Chairman & CEO Gangagen Inc
Mr
BN
Manohar, CEO, Stempeutics
Mr
Ganesh
Sambasivam, Founder & CSO, Anthem Biosciences